Molecure Statistics
Total Valuation
Molecure has a market cap or net worth of PLN 166.07 million. The enterprise value is 132.10 million.
Market Cap | 166.07M |
Enterprise Value | 132.10M |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Molecure has 20.20 million shares outstanding. The number of shares has increased by 20.16% in one year.
Current Share Class | 20.20M |
Shares Outstanding | 20.20M |
Shares Change (YoY) | +20.16% |
Shares Change (QoQ) | -34.20% |
Owned by Insiders (%) | 3.43% |
Owned by Institutions (%) | 20.00% |
Float | 14.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 47.61 |
PB Ratio | 1.69 |
P/TBV Ratio | 4.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.46 |
EV / Sales | 37.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.54 |
Financial Position
The company has a current ratio of 10.28, with a Debt / Equity ratio of 0.07.
Current Ratio | 10.28 |
Quick Ratio | 10.19 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | -0.23 |
Interest Coverage | -610.87 |
Financial Efficiency
Return on equity (ROE) is -30.82% and return on invested capital (ROIC) is -18.60%.
Return on Equity (ROE) | -30.82% |
Return on Assets (ROA) | -17.68% |
Return on Invested Capital (ROIC) | -18.60% |
Return on Capital Employed (ROCE) | -29.58% |
Revenue Per Employee | 37,110 |
Profits Per Employee | -315,249 |
Employee Count | 102 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.34% in the last 52 weeks. The beta is 2.59, so Molecure's price volatility has been higher than the market average.
Beta (5Y) | 2.59 |
52-Week Price Change | -47.34% |
50-Day Moving Average | 8.44 |
200-Day Moving Average | 10.52 |
Relative Strength Index (RSI) | 43.60 |
Average Volume (20 Days) | 11,143 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Molecure had revenue of PLN 3.49 million and -29.63 million in losses. Loss per share was -1.41.
Revenue | 3.49M |
Gross Profit | 170,996 |
Operating Income | -30.59M |
Pretax Income | -29.63M |
Net Income | -29.63M |
EBITDA | -30.90M |
EBIT | -30.59M |
Loss Per Share | -1.41 |
Balance Sheet
The company has 40.66 million in cash and 6.69 million in debt, giving a net cash position of 33.97 million or 1.68 per share.
Cash & Cash Equivalents | 40.66M |
Total Debt | 6.69M |
Net Cash | 33.97M |
Net Cash Per Share | 1.68 |
Equity (Book Value) | 98.21M |
Book Value Per Share | 4.86 |
Working Capital | 37.52M |
Cash Flow
In the last 12 months, operating cash flow was -28.69 million and capital expenditures -420,981, giving a free cash flow of -29.11 million.
Operating Cash Flow | -28.69M |
Capital Expenditures | -420,981 |
Free Cash Flow | -29.11M |
FCF Per Share | -1.44 |
Margins
Gross Margin | 4.90% |
Operating Margin | -876.94% |
Pretax Margin | -849.49% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Molecure does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.16% |
Shareholder Yield | n/a |
Earnings Yield | -17.84% |
FCF Yield | -17.53% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Molecure has an Altman Z-Score of 11.84.
Altman Z-Score | 11.84 |
Piotroski F-Score | n/a |